Oncology & Cancer

Researchers make progress in glioblastoma multiforme research

A  research team, with the participation of the University of Granada (UGR), has made some progress in determining why glioblastoma multiforme (GBM), one of the most aggressive brain tumors known, is resistant to existing ...

Oncology & Cancer

Metabolic compensation underlies drug resistance in glioblastoma

Gliobststoma (GBM) is a highly aggressive brain tumor that is resistant to many conventional cancer therapies. The kinase mTOR induces pathways that are aberrantly activated in GBM. However, mTOR inhibitors have not shown ...

page 4 from 6